Implantable defibrillators versus medical therapy for cardiac channelopathies

David A. Mcnamara*, Jeffrey J. Goldberger, Mark A. Berendsen, Mark D. Huffman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the effectiveness of ICDs with antiarrhythmic drugs, placebo, or usual care in reducing the risk of all-cause mortality, cardiovascular mortality, and adverse events in individuals at increased risk of sudden cardiac death due to cardiac ion channelopathies, including congenital long QT syndrome, congential short QT syndrome, Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia.

Original languageEnglish (US)
Article numberCD011168
JournalCochrane Database of Systematic Reviews
Issue number6
StatePublished - Jun 25 2014

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Implantable defibrillators versus medical therapy for cardiac channelopathies'. Together they form a unique fingerprint.

Cite this